» Articles » PMID: 20042588

Peripheral Blood CCR4+CCR6+ and CXCR3+CCR6+CD4+ T Cells Are Highly Permissive to HIV-1 Infection

Abstract

There is limited knowledge on the identity of primary CD4(+) T cell subsets selectively targeted by HIV-1 in vivo. In this study, we established a link between HIV permissiveness, phenotype/homing potential, and lineage commitment in primary CD4(+) T cells. CCR4(+)CCR6(+), CCR4(+)CCR6(-), CXCR3(+)CCR6(+), and CXCR3(+)CCR6(-) T cells expressed cytokines and transcription factors specific for Th17, Th2, Th1Th17, and Th1 lineages, respectively. CCR4(+)CCR6(+) and CXCR3(+)CCR6(+) T cells expressed the HIV coreceptors CCR5 and CXCR4 and were permissive to R5 and X4 HIV replication. CCR4(+)CCR6(-) T cells expressed CXCR4 but not CCR5 and were permissive to X4 HIV only. CXCR3(+)CCR6(-) T cells expressed CCR5 and CXCR4 but were relatively resistant to R5 and X4 HIV in vitro. Total CCR6(+) T cells compared with CCR6(-) T cells harbored higher levels of integrated HIV DNA in treatment-naive HIV-infected subjects. The frequency of total CCR6(+) T cells and those of CCR4(+)CCR6(+) and CXCR3(+)CCR6(+) T cells were diminished in chronically infected HIV-positive subjects, despite viral-suppressive therapy. A high-throughput analysis of cytokine profiles identified CXCR3(+)CCR6(+) T cells as a major source of TNF-alpha and CCL20 and demonstrated a decreased TNF-alpha/IL-10 ratio in CXCR3(+)CCR6(-) T cells. Finally, CCR4(+)CCR6(+) and CXCR3(+)CCR6(+) T cells exhibited gut- and lymph node-homing potential. Thus, we identified CCR4(+)CCR6(+) and CXCR3(+)CCR6(+) T cells as highly permissive to HIV replication, with potential to infiltrate and recruit more CCR6(+) T cells into anatomic sites of viral replication. It is necessary that new therapeutic strategies against HIV interfere with viral replication/persistence in discrete CCR6(+) T cell subsets.

Citing Articles

Tracking HIV persistence across T cell lineages during early ART-treated HIV-1-infection using a reservoir-marking humanized mouse model.

Satija N, Patel F, Schmidt G, Doanman D, Kapoor M, La Porte A Nat Commun. 2025; 16(1):2233.

PMID: 40044684 PMC: 11883074. DOI: 10.1038/s41467-025-57368-7.


Flow Cytometric Immunophenotyping: Minimal Differences in Fresh and Cryopreserved Peripheral Blood Mononuclear Cells versus Whole Blood.

Tompa A, Johansson J, Islander U, Faresjo M Biomedicines. 2024; 12(10).

PMID: 39457632 PMC: 11505181. DOI: 10.3390/biomedicines12102319.


Altered memory CCR6 Th17-polarised T-cell function and biology in people with HIV under successful antiretroviral therapy and HIV elite controllers.

Yero A, Goulet J, Shi T, Costiniuk C, Routy J, Tremblay C EBioMedicine. 2024; 107:105274.

PMID: 39178742 PMC: 11388266. DOI: 10.1016/j.ebiom.2024.105274.


The Complex Dysregulations of CD4 T Cell Subtypes in HIV Infection.

Tolomeo M, Cascio A Int J Mol Sci. 2024; 25(14).

PMID: 39062756 PMC: 11276885. DOI: 10.3390/ijms25147512.


CD70 identifies alloreactive T cells and represents a potential target for prevention and treatment of acute GVHD.

Verma K, Croft W, Margielewska-Davies S, Pearce H, Stephens C, Diaconescu D Blood Adv. 2024; 8(18):4900-4912.

PMID: 39028952 PMC: 11421336. DOI: 10.1182/bloodadvances.2024012909.


References
1.
Rabbi M, Finnegan A, Al-Harthi L, Song S, Roebuck K . Interleukin-10 enhances tumor necrosis factor-alpha activation of HIV-1 transcription in latently infected T cells. J Acquir Immune Defic Syndr Hum Retrovirol. 1998; 19(4):321-31. DOI: 10.1097/00042560-199812010-00002. View

2.
Boulassel M, Spurll G, Rouleau D, Tremblay C, Edwardes M, Sekaly R . Changes in immunological and virological parameters in HIV-1 infected subjects following leukapheresis. J Clin Apher. 2003; 18(2):55-60. DOI: 10.1002/jca.10051. View

3.
Brenchley J, Schacker T, Ruff L, Price D, Taylor J, Beilman G . CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med. 2004; 200(6):749-59. PMC: 2211962. DOI: 10.1084/jem.20040874. View

4.
Campbell J, Butcher E . Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. Curr Opin Immunol. 2000; 12(3):336-41. DOI: 10.1016/s0952-7915(00)00096-0. View

5.
Rivino L, Messi M, Jarrossay D, Lanzavecchia A, Sallusto F, Geginat J . Chemokine receptor expression identifies Pre-T helper (Th)1, Pre-Th2, and nonpolarized cells among human CD4+ central memory T cells. J Exp Med. 2004; 200(6):725-35. PMC: 2211963. DOI: 10.1084/jem.20040774. View